Literature DB >> 2318995

Lack of in vitro activity of omeprazole against Campylobacter pylori.

A M Ghelani, S Hale, H Coleman, H Radziwonik, C Robertson, M Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2318995      PMCID： PMC502306          DOI： 10.1136/jcp.43.2.171-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  1 in total

1.  Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.

Authors:  M V Borkent; J A Beker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059
  1 in total
  7 in total

1.  Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium.

Authors:  M A Greig; W D Neithercut; M Hossack; K E McColl
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

2.  Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.

Authors:  P D Midolo; J D Turnidge; J R Lambert; J M Bell
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.

Authors:  M Pérez-Paramo; A Albillos; J L Calleja; C Salas; M C Marín; M L Marcos; G Cacho; P Escartín; J Ortiz-Berrocal
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

4.  Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori.

Authors:  W M Hui; S K Lam; J Ho; C L Lai; A S Lok; M M Ng; W Y Lau; F J Branicki
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

5.  Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

Authors:  R P Logan; M M Walker; J J Misiewicz; P A Gummett; Q N Karim; J H Baron
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

6.  Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents.

Authors:  V G Loo; P Sherman; A G Matlow
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 7.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.